Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
59 studies found for:    Antiphospholipid Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Antiphospholipid Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Interventions: Biological: Antiphospholipid antibody tests;   Biological: Thrombophilia bloodwork;   Other: Psychiatric evaluation
2 Completed A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention: Drug: Rituximab
3 Recruiting Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Condition: Antiphospholipid Syndrome
Intervention:
4 Completed Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
5 Completed Antiphospholipid Syndrome Collaborative Registry (APSCORE)
Condition: Antiphospholipid Syndrome
Intervention:
6 Recruiting Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
7 Unknown  Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
Condition: Antiphospholipid Syndrome
Intervention: Drug: Fluvastatin
8 Recruiting Rivaroxaban in Thrombotic Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention: Drug: Experimental: Rivaroxaban
9 Recruiting Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Conditions: Systemic Lupus Erythematosus;   Antiphospholipid Syndrome
Intervention:
10 Active, not recruiting Pilot Study of Gut Commensals in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome (APS)
Intervention:
11 Withdrawn Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome
Condition: ANTIPHOSPHOLIPID SYNDROME
Intervention: Biological: Stem Cell Transplantation
12 Active, not recruiting Rivaroxaban for Patients With Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Interventions: Drug: Rivaroxaban;   Drug: acenocumarol
13 Recruiting Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome (APS)
Interventions: Drug: Hydroxychloroquine;   Drug: placebo
14 Not yet recruiting Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)
Conditions: Anti-Phospholipids Syndrome (APS);   Systemic Lupus Erythematosus (SLE)
Intervention:
15 Recruiting Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome
Conditions: Antiphospholipid Syndrome;   Thrombosis
Interventions: Drug: Apixaban;   Drug: Warfarin
16 Not yet recruiting AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
Conditions: Antiphospholipid Syndrome in Pregnancy;   Pregnancy Loss
Interventions: Drug: Aspirin 81 mg;   Drug: Low-molecular-weight heparin
17 Completed Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin
Condition: Antiphospholipid Syndrome
Intervention: Device: INR by point-of-care instruments and venopuncture
18 Recruiting Rivaroxaban for Antiphospholipid Antibody Syndrome
Condition: Antiphospholipid Antibody Syndrome
Intervention: Drug: Rivaroxaban
19 Completed The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
Condition: Antiphospholipid Syndrome
Intervention:
20 Completed
Has Results
Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome
Condition: Recurrent Abortion
Interventions: Drug: enoxaparin 40mg plus low dose aspirin;   Drug: Heparin calcium5,000 U twice daily plus low dose aspirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.